A New Risk Factor for Cardiovascular Events in Patients Receiving Immune Checkpoint Inhibitor Therapy?

[Figure: see text]

Detalles Bibliográficos
Autores principales: Thavendiranathan, Paaladinesh, Sacher, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830213/
https://www.ncbi.nlm.nih.gov/pubmed/36636452
http://dx.doi.org/10.1016/j.jaccao.2022.11.010
_version_ 1784867625154641920
author Thavendiranathan, Paaladinesh
Sacher, Adrian
author_facet Thavendiranathan, Paaladinesh
Sacher, Adrian
author_sort Thavendiranathan, Paaladinesh
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-9830213
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98302132023-01-11 A New Risk Factor for Cardiovascular Events in Patients Receiving Immune Checkpoint Inhibitor Therapy? Thavendiranathan, Paaladinesh Sacher, Adrian JACC CardioOncol Original Research [Figure: see text] Elsevier 2022-12-20 /pmc/articles/PMC9830213/ /pubmed/36636452 http://dx.doi.org/10.1016/j.jaccao.2022.11.010 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Thavendiranathan, Paaladinesh
Sacher, Adrian
A New Risk Factor for Cardiovascular Events in Patients Receiving Immune Checkpoint Inhibitor Therapy?
title A New Risk Factor for Cardiovascular Events in Patients Receiving Immune Checkpoint Inhibitor Therapy?
title_full A New Risk Factor for Cardiovascular Events in Patients Receiving Immune Checkpoint Inhibitor Therapy?
title_fullStr A New Risk Factor for Cardiovascular Events in Patients Receiving Immune Checkpoint Inhibitor Therapy?
title_full_unstemmed A New Risk Factor for Cardiovascular Events in Patients Receiving Immune Checkpoint Inhibitor Therapy?
title_short A New Risk Factor for Cardiovascular Events in Patients Receiving Immune Checkpoint Inhibitor Therapy?
title_sort new risk factor for cardiovascular events in patients receiving immune checkpoint inhibitor therapy?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830213/
https://www.ncbi.nlm.nih.gov/pubmed/36636452
http://dx.doi.org/10.1016/j.jaccao.2022.11.010
work_keys_str_mv AT thavendiranathanpaaladinesh anewriskfactorforcardiovasculareventsinpatientsreceivingimmunecheckpointinhibitortherapy
AT sacheradrian anewriskfactorforcardiovasculareventsinpatientsreceivingimmunecheckpointinhibitortherapy
AT thavendiranathanpaaladinesh newriskfactorforcardiovasculareventsinpatientsreceivingimmunecheckpointinhibitortherapy
AT sacheradrian newriskfactorforcardiovasculareventsinpatientsreceivingimmunecheckpointinhibitortherapy

Ejemplares similares